NCT07204847

Brief Summary

The objective of this multicentric observational study is to evaluate the prognostic influence of adherence or non-adherence to the recommended coronary angiography timeframe (within 24 hours) and the six-month prognosis of the patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
407

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

October 2, 2025

Completed
Last Updated

October 2, 2025

Status Verified

September 1, 2025

Enrollment Period

1.5 years

First QC Date

September 15, 2025

Last Update Submit

September 24, 2025

Conditions

Keywords

NSTEMINSTE-ACSInvasive strategy timingEarly or delayed intervention

Outcome Measures

Primary Outcomes (1)

  • Describe the predictive value of the timing of invasive coronary angiography on a composite criteria of overall mortality, recurrent myocardial infarction, stroke, hospitalization for heart failure at 6 months

    Sensibility and specificity, positive and negative predictive values

    From enrollment to 6 months

Secondary Outcomes (7)

  • Evaluation of the optimal timing of invasive coronary angiography predicting a negative outcome at 6 months

    From enrollment to 6 months

  • Comparison of the composite criteria of an invasive coronary angiography within 24h and after 24h at 6 months

    From enrollment to 6 months

  • Comparison of the composite criteria of an invasive coronary angiography within 24h and after 24h at 1 month

    From enrollment to 1 month

  • Comparison of each element of the composite criteria individually at 6 months of an invasive coronary angiography within 24h and after 24h

    From enrollment to 6 months

  • Describe the prevalence of patients receiving an invasive in respect to the timing of the guidelines

    At enrollment

  • +2 more secondary outcomes

Study Arms (2)

Early intervention

Invasive coronary angiography within 24 hours after diagnosis

Delayed intervention

Invasive coronary angiography more than 24 hours after diagnosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The included patients are those diagnosed with NSTEMI who have undergone coronary angiography as recommended, with no changes to the subsequent patient follow-up

You may qualify if:

  • Presence of chest pain with or without ECG changes
  • Elevation of troponin level \> 90th percentile or a significant increase between two dosages

You may not qualify if:

  • STEMI (ST-segment elevation myocardial infarction) or equivalent (defined as chest pain with ECG changes and troponin elevation \> 5 times the normal with an occluded artery (TIMI 0, 1, or 2) during initial coronary angiography)
  • Very high-risk NSTEMI (hemodynamic instability, cardiogenic shock, recurrent/refractory chest pain despite optimal medical treatment, life-threatening arrhythmia, mechanical complication, heart failure clearly related to NSTEMI, ST depression \> 1mm/6 leads with ST elevation in aVR and/or V1) for which urgent coronary angiography is mandatory
  • Unstable angina (acute coronary syndrome without troponin elevation)
  • Troponin elevation without chest pain or symptoms suggestive of NSTEMI
  • Recovered cardiac arrest
  • Contraindication to coronary revascularization or coronary angiography
  • Other diagnoses considered after coronary angiography (e.g., myocarditis, Takotsubo syndrome)
  • Age \< 18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Montpellier

Montpellier, 34000, France

Location

Related Publications (4)

  • Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JG, Lagerqvist B, Wallentin L; FIR Collaboration. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol. 2010 Jun 1;55(22):2435-45. doi: 10.1016/j.jacc.2010.03.007. Epub 2010 Mar 30.

    PMID: 20359842BACKGROUND
  • Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, Afzal R, Chrolavicius S, Jolly SS, Widimsky P, Avezum A, Rupprecht HJ, Zhu J, Col J, Natarajan MK, Horsman C, Fox KA, Yusuf S; TIMACS Investigators. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009 May 21;360(21):2165-75. doi: 10.1056/NEJMoa0807986.

    PMID: 19458363BACKGROUND
  • Kofoed KF, Kelbaek H, Hansen PR, Torp-Pedersen C, Hofsten D, Klovgaard L, Holmvang L, Helqvist S, Jorgensen E, Galatius S, Pedersen F, Bang L, Saunamaki K, Clemmensen P, Linde JJ, Heitmann M, Wendelboe Nielsen O, Raymond IE, Kristiansen OP, Svendsen IH, Bech J, Dominguez Vall-Lamora MH, Kragelund C, Hansen TF, Dahlgaard Hove J, Jorgensen T, Fornitz GG, Steffensen R, Jurlander B, Abdulla J, Lyngbaek S, Elming H, Therkelsen SK, Abildgaard U, Jensen JS, Gislason G, Kober LV, Engstrom T. Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. Circulation. 2018 Dec 11;138(24):2741-2750. doi: 10.1161/CIRCULATIONAHA.118.037152.

    PMID: 30565996BACKGROUND
  • Kite TA, Kurmani SA, Bountziouka V, Cooper NJ, Lock ST, Gale CP, Flather M, Curzen N, Banning AP, McCann GP, Ladwiniec A. Timing of invasive strategy in non-ST-elevation acute coronary syndrome: a meta-analysis of randomized controlled trials. Eur Heart J. 2022 Sep 1;43(33):3148-3161. doi: 10.1093/eurheartj/ehac213.

    PMID: 35514079BACKGROUND

MeSH Terms

Conditions

Non-ST Elevated Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2025

First Posted

October 2, 2025

Study Start

November 1, 2023

Primary Completion

May 1, 2025

Study Completion

June 20, 2025

Last Updated

October 2, 2025

Record last verified: 2025-09

Locations